Related Experiment Video
Updated: Nov 2, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.4K
Data-Driven Forecasting of Agitation for Persons with Dementia: A Deep Learning-Based Approach
SeyyedPooya HekmatiAthar1, Hilda Goins1, Raymond Samuel2
1Department of Computer Science, North Carolina A&T State University, Greensboro, NC USA.
Summary
This study predicts agitation in persons with dementia (PwD) using deep learning, reducing caregiver burden. Early forecasting of agitation episodes improves quality of life for informal caregivers.
Area of Science:
- Artificial Intelligence in Healthcare
- Neuroscience and Neurology
- Gerontology and Geriatric Care
Background:
- Millions diagnosed with dementia annually, with most cared for by family.
- Caregiver burden significantly impacts informal caregivers' quality of life.
- Unpredictable agitation episodes in persons with dementia (PwD) are a major stressor for caregivers.
Purpose of the Study:
- To develop a predictive model for agitation episodes in PwD.
- To reduce caregiver burden by enabling proactive management of agitation.
- To enhance the quality of life for familial caregivers of PwD.
Main Methods:
- Utilized Long Short-Term Memory (LSTM) deep learning models for forecasting.
- Predicted agitation events up to 30 minutes in advance.
- Handled missing data via imputation and addressed class imbalance through down-sampling.
Main Results:
- Achieved high prediction accuracy of 98.6% for agitation episodes.
- Demonstrated a recall (sensitivity) of 84.8% in predicting agitation.
- Validated model efficacy using real-world data from Alzheimer's disease caregiver-patient dyads.
Conclusions:
- Data-driven deep learning models are effective in predicting agitation in community-dwelling PwD.
- Forecasting agitation can significantly alleviate caregiver burden.
- This approach holds promise for improving caregiving experiences and patient well-being.
Related Concept Videos
Dementia
268
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
268
Alzheimer's Disease: Treatment
454
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
454
Alzheimer's Disease: Overview
941
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
941

